All Stories

  1. Assessing In Silico Tools for Accurate Pathogenicity Prediction in CHD Nucleosome Remodelers
  2. Defining the clinical spectrum and genotype-phenotype correlations for CCDC115-CDG: A patient report and review of the literature
  3. PIGC-related encephalopathy: Lessons learned from 18 new probands
  4. Early-onset systemic lupus erythematosus-ANCA-associated vasculitis overlap syndrome caused by DNASE1L3 deficiency
  5. Molecular Landscape in Limb Anomalies: Diagnostic Yield and New Candidate Genes
  6. The NuRD component CHD3 promotes BMP signalling during cranial neural crest cell specification
  7. A missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia
  8. Neurobehavioral profile of individuals with pathogenic variants in CHD3
  9. Transcriptomic and lipidomic profiling provide novel insight into the pathogenesis of monogenic SGMS2-related osteoporosis
  10. Pain experience and perception in individuals with Snijders Blok-Campeau syndrome
  11. Variable expressivity of a transmitted pathogenic KAT6B variant
  12. Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)
  13. Mechanistic insights into 16p13.3 microdeletions encompassing TBC1D24 and ATP6V0C through advanced sequencing approaches
  14. Variants in DENND2B are associated with vulnerability for neurodevelopmental impairment, psychosis and catatonia
  15. Frequency enrichment of coding variants in a French-Canadian founder population and its implication for inflammatory bowel diseases
  16. PTPN11 mutation: Orthopedic outcomes in metachondromatosis
  17. Glycosylphosphatidylinositol Biosynthesis Defect Due To Novel Biallelic Pathogenic Variants in PIGW
  18. Mucopolysaccharidosis Type IIIB With Pancytopenia: A Case Report and Hematological Correlations in Mice
  19. Clinical and Genetic Characterization of 8 Patients with Syndromic Patterned Cutaneous Hypopigmentation: A Descriptive Study
  20. Case Report: Gingival Hyperplasia and Scoliosis as Additional Features of EMC10‐Related Neurodevelopmental Disorder
  21. CHD3 Regulates BMP Signalling Response During Cranial Neural Crest Cell Specification
  22. Neurobehavioral profile of individuals with pathogenic variants in CHD3
  23. CHD3 regulates BMP signalling response during cranial neural crest cell specification
  24. Congenital Bone Disorders Associated with ERI1-Mediated RNA Metabolism Dysfunction: Spondylo-Epi-Metaphyseal Dysplasia Guo-Campeau Type and Beyond
  25. Expanding PIGM‐related disorders to coding mutations
  26. Discovery of a DNA methylation profile in individuals with Sifrim-Hitz-Weiss syndrome
  27. Long-term outcomes of MPS IVA patients treated with elosulfase alfa: Findings from the Morquio A Registry Study (MARS) after 10 years
  28. Real-world treatment with elosulfase alfa in patients with MPS IVA is associated with improved endurance over time
  29. Real-World Experience of Switching to Taliglucerase Among Patients with Gaucher Disease in Québec: A Case Series
  30. Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability
  31. P094: Dimethylglycine dehydrogenase deficiency in siblings with skeletal and neurodevelopmental manifestations
  32. Assessing in silico Tools for Accurate Pathogenicity Prediction in CHD Nucleosome Remodelers
  33. A novel ZMIZ1 variant associated with NEDDFSA and new ocular features: case report and review of literature
  34. The integral role of fibronectin in skeletal morphogenesis and pathogenesis
  35. Fibronectin isoforms promote postnatal skeletal development
  36. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder
  37. BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations
  38. Recessive Variants in PIGG Cause a Motor Neuropathy with Variable Conduction Block, Childhood Tremor, and Febrile Seizures: Expanding the Phenotype
  39. Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurement
  40. Mutations in fibronectin dysregulate chondrogenesis in skeletal dysplasia
  41. Dominantly acting variants in ATP6V1C1 and ATP6V1B2 cause a multisystem phenotypic spectrum by altering lysosomal and/or autophagosome function
  42. TBC1D24 regulates mitochondria and endoplasmic reticulum-mitochondria contact sites
  43. Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders
  44. A Genotype/Phenotype Study of KDM5B-Associated Disorders Suggests a Pathogenic Effect of Dominantly Inherited Missense Variants
  45. MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature
  46. Mild phenotypes in patients with different deletions in the 3′ enhancer region of SHOX
  47. Model matchmaking via the Solve-RD Rare Disease Models & Mechanisms Network (RDMM-Europe)
  48. 16p13.3 homologous sequences underlie microdeletions encompassing TBC1D24 and ATP6V0C
  49. Bi‐allelic variants in MYH3 cause recessively‐inherited arthrogryposis
  50. Functional studies in yeast confirm the pathogenicity of a new GINS3Meier–Gorlin syndrome variant
  51. Homozygous variant inTKFCabolishing triokinase activities is associated with isolated immunodeficiency
  52. Author response for "Functional studies in yeast confirm the pathogenicity of a new <i>GINS3</i><scp>Meier–Gorlin</scp> syndrome variant"
  53. Mono-allelic KCNB2 variants lead to a neurodevelopmental syndrome caused by altered channel inactivation
  54. The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders
  55. Role of Fibronectin in Postnatal Skeletal Development
  56. Disease-relevant mutations in Kv2.2 have drastic effects on inactivation properties of the channel
  57. OXR1 maintains the retromer to delay brain aging under dietary restriction
  58. Exploring the phenotypic spectrum and osteopenia mechanisms in Yunis-Varón syndrome
  59. Mutations in Fibronectin Dysregulate Chondrogenesis in Corner Fracture Type Spondylometaphyseal Dysplasia
  60. An adult patient with Tatton–Brown–Rahman syndrome caused by a novel DNMT3A variant and axonal polyneuropathy
  61. Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals
  62. Gpr18 agonist dampens inflammation, enhances myogenesis, and restores muscle function in models of Duchenne muscular dystrophy
  63. PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework
  64. The ATP6V1B2 DDOD/DOORS-Associated p.Arg506* Variant Causes Hyperactivity and Seizures in Mice
  65. Null and missense mutations of ERI1 cause a recessive phenotypic dichotomy in humans
  66. The <em>ATP6V1B2 </em>DDOD/DOORS-Associated p.Arg506* Variant Causes Hyperactivity and Seizures in Mice
  67. Monoallelic intragenic POU3F2 variants lead to neurodevelopmental delay and hyperphagic obesity, confirming the gene’s candidacy in 6q16.1 deletions
  68. The Quebec Dental Anomalies Registry: Identifying genes for rare disorders
  69. DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants
  70. 899 Phenotypic and genomic characterization of eight patients with patterned cutaneous hypopigmentation associated with extracutaneous findings
  71. Biallelic variants inDNA2cause poikiloderma with congenital cataracts and severe growth failure reminiscent of Rothmund-Thomson syndrome
  72. Elucidating the clinical and molecular spectrum ofSMARCC2-associated NDD in a cohort of 65 affected individuals
  73. A clustering of heterozygous missense variants in the crucial chromatin modifier WDR5 defines a new neurodevelopmental disorder
  74. Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition
  75. A Case of Bilateral Microphthalmia and Extensive Colobomas of the Globes Associated with a Likely Pathogenic Homozygous <i>SIX6</i> Variant
  76. ATP6V0C variants impair vacuolar V-ATPase causing a neurodevelopmental disorder often associated with epilepsy
  77. Findings from the Morquio A Registry Study (MARS) after 6 years: Long-term outcomes of MPS IVA patients treated with elosulfase alfa
  78. Fibronectin isoforms in skeletal development and associated disorders
  79. Functional correlation of genome‐wide DNA methylation profiles in genetic neurodevelopmental disorders
  80. MED27 , SLC6A7, and MPPE1 Variants in a Complex Neurodevelopmental Disorder with Severe Dystonia
  81. DNA Methylation Signature for JARID2-Neurodevelopmental Syndrome
  82. Ethanolamine‐phosphate on the second mannose is a preferential bridge for some GPI‐anchored proteins
  83. Hypomorphic GINS3 variants alter DNA replication and cause Meier-Gorlin syndrome
  84. OXR1 maintains the retromer to delay brain aging under dietary restriction
  85. A Discussion With Dr. Philippe Campeau, Medical Geneticist and Clinician-Scientist
  86. Inherited variants in CHD3 show variable expressivity in Snijders Blok-Campeau syndrome
  87. C18orf32 loss-of-function is associated with a neurodevelopmental disorder with hypotonia and contractures
  88. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders
  89. Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males
  90. Variable expressivity in a family with an aggrecanopathy
  91. Heterozygous variant in WNT1 gene in two brothers with early onset osteoporosis
  92. Calvarial doughnut lesions with bone fragility in a French-Canadian family; case report and review of the literature
  93. Correction to: Establishing a core outcome set for mucopolysaccharidoses (MPS) in children: study protocol for a rapid literature review, candidate outcomes survey, and Delphi surveys
  94. International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia
  95. Establishing a core outcome set for mucopolysaccharidoses (MPS) in children: study protocol for a rapid literature review, candidate outcomes survey, and Delphi surveys
  96. A clustering of missense variants in the crucial chromatin modifier WDR5 defines a new neurodevelopmental disorder
  97. An all-encompassing variant classification system proposed
  98. Expanding the Phenotypic Spectrum of GPI Anchoring Deficiency Due to Biallelic Variants in GPAA1
  99. Inherited variants in CHD3 demonstrate variable expressivity in Snijders Blok-Campeau syndrome
  100. BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations
  101. Epileptic encephalopathy caused by ARV1 deficiency: Refinement of the genotype–phenotype spectrum and functional impact on GPI ‐anchored proteins
  102. PIGG variant pathogenicity assessment reveals characteristic features within 19 families
  103. Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders
  104. Rickets manifestations in a child with metaphyseal anadysplasia, report of a spontaneously resolving case
  105. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy
  106. Response to Gao et al.
  107. Haploinsufficiency of the Sin3/HDAC corepressor complex member SIN3B causes a syndromic intellectual disability/autism spectrum disorder
  108. Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availability
  109. Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository
  110. Free GPI is the elusive Emm antigen
  111. Disruption of exon-bridging interactions between the minor and major spliceosomes results in alternative splicing around minor introns
  112. Expanding the phenotype of PIGS ‐associated early onset epileptic developmental encephalopathy
  113. PIGF deficiency causes a phenotype overlapping with DOORS syndrome
  114. UBR7 functions with UBR5 in the Notch signaling pathway and is involved in a neurodevelopmental syndrome with epilepsy, ptosis, and hypothyroidism
  115. Missense substitutions at a conserved 14-3-3 binding site in HDAC4 cause a novel intellectual disability syndrome
  116. Correction: DOORS syndrome and a recurrent truncating ATP6V1B2 variant
  117. A homozygous variant in the Lamin B receptor gene LBR results in a non-lethal skeletal dysplasia without Pelger-Huët anomaly
  118. PIGH deficiency can be associated with severe neurodevelopmental and skeletal manifestations
  119. Ethanolamine phosphate on the second mannose as bridge in GPI anchored proteins: Towards understanding inherited PIGG deficiency
  120. JARID2 haploinsufficiency is associated with a clinically distinct neurodevelopmental syndrome
  121. Clinical characteristics of patients from Quebec, Canada, with Morquio A syndrome: a longitudinal observational study
  122. Biallelic variants in GLE1 with survival beyond neonatal period
  123. DOORS syndrome and a recurrent truncating ATP6V1B2 variant
  124. Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the ATP6V1B2 Gene
  125. Early infantile epileptic encephalopathy due to biallelic pathogenic variants in PIGQ : Report of seven new subjects and review of the literature
  126. Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7)
  127. De Novo KAT5 Variants Cause a Syndrome with Recognizable Facial Dysmorphisms, Cerebellar Atrophy, Sleep Disturbance, and Epilepsy
  128. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction
  129. Disrupted minor intron splicing is prevalent in Mendelian disorders
  130. A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndrome
  131. The minor and major spliceosome interact to regulate alternative splicing around minor introns
  132. Further delineation of the clinical spectrum of KAT6B disorders and allelic series of pathogenic variants
  133. Bi-allelic Variants in the GPI Transamidase Subunit PIGK Cause a Neurodevelopmental Syndrome with Hypotonia, Cerebellar Atrophy, and Epilepsy
  134. Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders
  135. Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development
  136. Correction: The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype–phenotype correlations, and molecular basis
  137. The Canadian Rare Diseases Models and Mechanisms (RDMM) Network: Connecting Understudied Genes to Model Organisms
  138. Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer
  139. Retrospective analysis of fetal vertebral defects: Associated anomalies, etiologies, and outcome
  140. Genetic burden contributing to extremely low or high bone mineral density in a senior male population from the Osteoporotic Fractures in Men (MrOS) study
  141. Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability
  142. A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder
  143. Loss of Oxidation Resistance 1, OXR1, Is Associated with an Autosomal-Recessive Neurological Disease with Cerebellar Atrophy and Lysosomal Dysfunction
  144. A variant of neonatal progeroid syndrome, or Wiedemann–Rautenstrauch syndrome, is associated with a nonsense variant in POLR3GL
  145. A de novo frameshift FGFR1 mutation extending the protein in an individual with multiple epiphyseal dysplasia and hypogonadotropic hypogonadism without anosmia
  146. Nonsyndromic erythrodermic ichthyosis resulting from a homozygous mutation in PIGL
  147. Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy
  148. Mutations in ANAPC1, Encoding a Scaffold Subunit of the Anaphase-Promoting Complex, Cause Rothmund-Thomson Syndrome Type 1
  149. Correction: A new microdeletion syndrome involving TBC1D24, ATP6V0C, and PDPK1 causes epilepsy, microcephaly, and developmental delay
  150. Estimating the effect size of the 15Q11.2 BP1–BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice
  151. The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype–phenotype correlations, and molecular basis
  152. Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation
  153. Mutations in PIGB Cause an Inherited GPI Biosynthesis Defect with an Axonal Neuropathy and Metabolic Abnormality in Severe Cases
  154. Polyhydramnios: sole risk factor for non-traumatic fractures in two infants
  155. Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome
  156. Inherited glycophosphatidylinositol deficiency variant database and analysis of pathogenic variants
  157. Biallelic variants in the transcription factor PAX7 are a new genetic cause of myopathy
  158. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language
  159. Mutations in ACTL6B Cause Neurodevelopmental Deficits and Epilepsy and Lead to Loss of Dendrites in Human Neurons
  160. A Syndromic Neurodevelopmental Disorder Caused by Mutations in SMARCD1, a Core SWI/SNF Subunit Needed for Context-Dependent Neuronal Gene Regulation in Flies
  161. Novel fibronectin mutations and expansion of the phenotype in spondylometaphyseal dysplasia with “corner fractures”
  162. Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes
  163. Missense Variants in the Histone Acetyltransferase Complex Component Gene TRRAP Cause Autism and Syndromic Intellectual Disability
  164. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language
  165. Correction: The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin–Siris syndrome
  166. Genetics of the patella
  167. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay
  168. Genomic Study of Severe Fetal Anomalies and Discovery of GREB1L Mutations in Renal Agenesis
  169. BAFopathies’ DNA methylation epi-signatures demonstrate diagnostic utility and functional continuum of Coffin–Siris and Nicolaides–Baraitser syndromes
  170. The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin–Siris syndrome
  171. MYOD1 involvement in myopathy
  172. Mutations in the gene CHD3 can cause a language disorder with cognitive delays and a larger head.
  173. Hot water epilepsy and SYN1 variants
  174. Lowry-Wood syndrome: further evidence of association with RNU4ATAC, and correlation between genotype and phenotype
  175. The epilepsy-associated protein TBC1D24 is required for normal development, survival and vesicle trafficking in mammalian neurons
  176. Correction: IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients
  177. Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy
  178. Identification of SMARCD1 as a syndromic intellectual disability gene that is required for memory and context-dependent regulation of neuronal genes in Drosophila
  179. A new microdeletion syndrome involving TBC1D24, ATP6V0C, and PDPK1 causes epilepsy, microcephaly, and developmental delay
  180. IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients
  181. Arginase overexpression in neurons and its effect on traumatic brain injury
  182. Clinical variability in inherited glycosylphosphatidylinositol deficiency disorders
  183. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells
  184. A PIGH mutation leading to GPI deficiency is associated with developmental delay and autism
  185. Recessive mutations in >VPS13D cause childhood onset movement disorders
  186. Recessive loss of function PIGN alleles, including an intragenic deletion with founder effect in La Réunion Island, in patients with Fryns syndrome
  187. Dysregulation of cotranscriptional alternative splicing underlies CHARGE syndrome
  188. Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes
  189. FRMPD4 mutations cause X-linked intellectual disability and disrupt dendritic spine morphogenesis
  190. Neural Glycosylphosphatidylinositol-Anchored Proteins in Synaptic Specification
  191. High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
  192. Mutations in Fibronectin Cause a Subtype of Spondylometaphyseal Dysplasia with “Corner Fractures”
  193. Mutations in GPAA1 , Encoding a GPI Transamidase Complex Protein, Cause Developmental Delay, Epilepsy, Cerebellar Atrophy, and Osteopenia
  194. Genomic study of severe fetal anomalies and discovery of GREB1L mutations in renal agenesis
  195. Genomic approaches to diagnose rare bone disorders
  196. A non-mosaic PORCN mutation in a male with severe congenital anomalies overlapping focal dermal hypoplasia
  197. Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic Research
  198. Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR)
  199. A challenging case of hyperphosphatemic tumoral calcinosis
  200. Heterozygous variants in ACTL6A , encoding a component of the BAF complex, are associated with intellectual disability
  201. Retrospective Analysis of Congenital Scoliosis
  202. A Novel PGM3 Mutation Is Associated With a Severe Phenotype of Bone Marrow Failure, Severe Combined Immunodeficiency, Skeletal Dysplasia, and Congenital Malformations
  203. Yunis-Varón syndrome caused by biallelic VAC14 mutations
  204. TBC1D24 associated with autosomal dominant tonic-clonic and myoclonic epilepsy
  205. MicroRNA miR-23a cluster promotes osteocyte differentiation by regulating TGF-β signalling in osteoblasts
  206. Compound heterozygous mutations in the gene PIGP are associated with early infantile epileptic encephalopathy
  207. Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia
  208. The spectrum of infantile myofibromatosis includes both non-penetrance and adult recurrence
  209. An exome sequencing study of Moebius syndrome including atypical cases reveals an individual with CFEOM3A and aTUBB3mutation
  210. Chondrodysplasia with multiple dislocations: comprehensive study of a series of 30 cases
  211. Genetic Testing in a Cohort of Complex Esophageal Atresia
  212. Spondyloepimetaphysial Dysplasia with Joint Laxity in Three Siblings with B3GALT6 Mutations
  213. Kaufman oculo-cerebro-facial syndrome in a child with small and absent terminal phalanges and absent nails
  214. Mutations in the Chromatin Regulator Gene BRPF1 Cause Syndromic Intellectual Disability and Deficient Histone Acetylation
  215. Corner fracture type spondylometaphyseal dysplasia: Overlap with type II collagenopathies
  216. FHF1 (FGF12) epileptic encephalopathy: Table
  217. De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive Dysmorphisms
  218. Mutations in the phosphatidylinositol glycan C (PIGC) gene are associated with epilepsy and intellectual disability
  219. TBC1D24genotype–phenotype correlation
  220. LMX1B and the Nail-Patella Syndrome
  221. Epilepsy in KCNH1-related syndromes
  222. Small 6q16.1 Deletions Encompassing POU3F2 Cause Susceptibility to Obesity and Variable Developmental Delay with Intellectual Disability
  223. Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests
  224. Mutations Impairing GSK3-Mediated MAF Phosphorylation Cause Cataract, Deafness, Intellectual Disability, Seizures, and a Down Syndrome-like Facies
  225. Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome
  226. Canadian Open Genetics Repository (COGR): a unified clinical genomics database as a community resource for standardising and sharing genetic interpretations
  227. Adult presentation of X-linked Conradi-Hünermann-Happle syndrome
  228. FBN1contributing to familial congenital diaphragmatic hernia
  229. Exome Sequencing Identifies a Novel Homozygous Mutation in the Phosphate Transporter SLC34A1 in Hypophosphatemia and Nephrocalcinosis
  230. Erratum: Myhre and LAPS syndromes: clinical and molecular review of 32 patients
  231. Urea Cycle
  232. A longitudinal study of urea cycle disorders
  233. DOORS syndrome: Phenotype, genotype and comparison with Coffin-Siris syndrome
  234. Genotype–Phenotype Correlation — Promiscuity in the Era of Next-Generation Sequencing
  235. Argininosuccinate lyase in enterocytes protects from development of necrotizing enterocolitis
  236. A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers
  237. Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders
  238. Myhre and LAPS syndromes: clinical and molecular review of 32 patients
  239. The genetic basis of DOORS syndrome: an exome-sequencing study
  240. Diagnosis of ALG12-CDG by exome sequencing in a case of severe skeletal dysplasia
  241. The Undernourished Neonatal Mouse Metabolome Reveals Evidence of Liver and Biliary Dysfunction, Inflammation, and Oxidative Stress
  242. Mutation of KCNJ8 in a patient with Cantú syndrome with unique vascular abnormalities – Support for the role of K(ATP) channels in this condition
  243. Osteogenesis imperfecta without features of type V caused by a mutation in theIFITM5gene
  244. Phenotypic Variability of Osteogenesis Imperfecta Type V Caused by an IFITM 5 Mutation
  245. MCTP2 is a dosage-sensitive gene required for cardiac outflow tract development
  246. A Recurrent PDGFRB Mutation Causes Familial Infantile Myofibromatosis
  247. WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta identify a key WNT ligand regulating bone mass
  248. Structure-based design and mechanisms of allosteric inhibitors for mitochondrial branched-chain α-ketoacid dehydrogenase kinase
  249. WNT1Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta
  250. Yunis-Varón Syndrome Is Caused by Mutations in FIG4, Encoding a Phosphoinositide Phosphatase
  251. Early childhood presentation of Czech dysplasia
  252. Next-generation sequencing for disorders of low and high bone mineral density
  253. Identification of Novel Mutations ConfirmsPDE4Das a Major Gene Causing Acrodysostosis
  254. Identification of Novel Mutations ConfirmsPde4das a Major Gene Causing Acrodysostosis
  255. Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis
  256. TheKAT6B-related disorders genitopatellar syndrome and Ohdo/SBBYS syndrome have distinct clinical features reflecting distinct molecular mechanisms
  257. Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency
  258. Nitric-Oxide Supplementation for Treatment of Long-Term Complications in Argininosuccinic Aciduria
  259. miRNA-34c regulates Notch signaling during bone development
  260. Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome
  261. Requirement of argininosuccinate lyase for systemic nitric oxide production
  262. Early orthotopic liver transplantation in urea cycle defects: Follow up of a developmental outcome study
  263. Management of West Syndrome in a Patient With Methylmalonic Aciduria
  264. Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome
  265. Long-term outcome in methylmalonic aciduria: A series of 30 French patients
  266. Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner
  267. Clinical Heterogeneity in Ethylmalonic Encephalopathy
  268. Selective Inhibition of CCR2 Expressing Lymphomyeloid Cells in Experimental Autoimmune Encephalomyelitis by a GM-CSF-MCP1 Fusokine
  269. Mesenchymal Stromal Cells Engineered to Express Erythropoietin Induce Anti-erythropoietin Antibodies and Anemia in Allorecipients
  270. Prenatal diagnosis of monosomy 1p36: A focus on brain abnormalities and a review of the literature
  271. 57 Neo-organoid of mesenchymal stem cells engineered to secrete a CC-chemokine chimeric fusokine reverses EAE
  272. A 25-year longitudinal analysis of treatment efficacy in inborn errors of metabolism
  273. Hereditary breast cancer: new genetic developments, new therapeutic avenues
  274. Neurotransmitter diseases and related conditions
  275. Transfection of large plasmids in primary human myoblasts
  276. Functional EGFP–dystrophin fusion proteins for gene therapy vector development